Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites | Zendy

AI Assistant Blog Pricing

Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.